Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Biosyent Inc
V.RX
Alternate Symbol(s):
BIOYF
Healthcare
BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing...
biologically and health friendly non-chemical insecticides. Its products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Maintenance 45, FeraMAX Pd Powder 15, Gelclair, Inofolic, Proktis-M, RepaGyn, and Tibella. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Cathejell combines sterile gel and 2% lidocaine jelly in a collapsible syringe that is ready to use. FeraMAX Pd Therapeutic 150 is an oral hematinic that helps the body form red blood cells and is indicated for the treatment of iron deficiency anemia.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:RX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
Next
(24)
•••
overnout
X
View Profile
View Bullboard History
Comment by
overnout
on Aug 03, 2022 11:34am
RE:Advil Introduces Advil PLUS Acetaminophen
Pricing will be interesting. Combogesic using generic ibuprofen compared to branded Advil ibuprofen. Thanks for finding that and sharing it here.
(1859)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Aug 03, 2022 8:18am
Advil Introduces Advil PLUS Acetaminophen
https://www.newswire.ca/news-releases/advil-introduces-advil-plus-acetaminophen-to-canadians-combining-two-trusted-pain-relievers-into-one-convenient-tablet-852670044.html
(1502)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Post by
Possibleidiot01
on Jul 05, 2022 3:17pm
jason del vicario - BNN - Past Top Pick
PAST TOP PICK BioSyent Inc(RX-X) 04/07/2022 at 08:00pm (A Top Pick Jun 01/21, Down 2%) Owner holds 17% of stock. No debt, high returns, asset lite and buying
...more
(9750)
•••
Karren411
X
View Profile
View Bullboard History
Comment by
Karren411
on May 02, 2022 5:32am
RE:RE:share buyback
(1862)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Apr 26, 2022 5:13pm
BioSyent to Present
MISSISSAUGA, Ontario, April 26, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2022 Bloom Burton & Co
...more
(2)
•••
microcap
X
View Profile
View Bullboard History
Comment by
microcap
on Apr 13, 2022 11:32pm
RE:RE:RE:share buyback
They were a few small sales by Wilson and Raghubir around the time of the annual share grant (RSUs). Hardly cause for concern. The three discontinued products totaled less than $2M in revenue in 2021
...more
(24)
•••
overnout
X
View Profile
View Bullboard History
Comment by
overnout
on Apr 13, 2022 4:15pm
RE:RE:RE:RE:share buyback
Dividend?
(1859)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Apr 13, 2022 3:15pm
RE:RE:RE:share buyback
Why would execs exercise options with $9.12 strike price and years to expiry?
(24)
•••
overnout
X
View Profile
View Bullboard History
Comment by
overnout
on Apr 13, 2022 1:10pm
RE:share buyback
Nice that they still see value in buying shares back north of $8
(1859)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Apr 13, 2022 12:51pm
share buyback
Filed 2022-04-10 09:12 Tx date 2022-03-31 $RX BioSyent Inc. Wilson, Kevin 5 - Senior Officer of Issuer Direct Ownership
...more
(24)
•••
overnout
X
View Profile
View Bullboard History
Post by
overnout
on Apr 13, 2022 12:36pm
$10
Not since June 2018 has RX traded in double digits. I do agree that there was a period of sketchy trading about a month ago, however, the last couple of weeks appear to be showing a more orderly
...more
(1859)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Mar 25, 2022 3:12pm
Sketchy trading
Date & Time Price ($) Shares Change ($) Buyer Seller
...more
(1859)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Mar 12, 2022 1:41pm
RE:Bloom Burton raises TP to $10
eps Forecast: 2022..... $0.54 2023......$0.60 2024......$0.66
(1859)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Mar 12, 2022 1:28pm
Bloom Burton raises TP to $10
From $8.50
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon